GHSR and sarcopenia: Studies and/or clinical trials report the beneficial effects of ghrelin [167,168] and an agonist for the ghrelin receptor (anamorelin) in the treatment of cancer-associated cachexia [166,169,170,171] and cancer-associated sarcopenia (reviewed in: [172]).